NASDAQ · BBOT
BridgeBio Oncology Therapeutics Inc.
Healthcare · Biotechnology
$2.14
Down-$0.16 (-7.48%)
Updated Nov 17, 2026, 1:52 AM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.03B
- P/E ratio
- -2.62
- Dividend yield
- 0.00%
- 52-week range
- $1.98 – $14.87
- Volume
- 677.6K
- Avg. volume
- 237.22K
Price performance · BBOT
BBOT price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
BBOT closed at $2.14 after 20 trading sessions, down 24.91% for the selected period.
- Last close
- $2.14
- Period change
- -24.91%
- Period low
- $2.04
- Period high
- $2.85
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $2.37 | $2.37 | $2.11 | $2.14 | 677.6K |
| Nov 12, 2026 | $2.50 | $2.68 | $2.00 | $2.35 | 779.14K |
| Nov 11, 2026 | $2.33 | $2.65 | $2.25 | $2.56 | 1.42M |
| Nov 10, 2026 | $2.29 | $2.34 | $2.185 | $2.20 | 486.87K |
| Nov 9, 2026 | $2.09 | $2.34 | $2.07 | $2.30 | 780.84K |
| Nov 6, 2026 | $2.19 | $2.25 | $1.98 | $2.04 | 687.05K |
| Nov 5, 2026 | $2.30 | $2.30 | $2.07 | $2.17 | 699.09K |
| Nov 4, 2026 | $2.33 | $2.39 | $2.22 | $2.30 | 451.53K |
| Nov 3, 2026 | $2.30 | $2.4025 | $2.29 | $2.32 | 621.27K |
| Nov 2, 2026 | $2.64 | $2.64 | $2.295 | $2.31 | 579.58K |
| Oct 30, 2026 | $2.70 | $2.74 | $2.605 | $2.62 | 314.79K |
| Oct 29, 2026 | $2.81 | $2.9475 | $2.69 | $2.70 | 357.04K |
| Oct 28, 2026 | $2.67 | $2.855 | $2.61 | $2.80 | 482.22K |
| Oct 27, 2026 | $2.65 | $2.725 | $2.51 | $2.69 | 1.76M |
| Oct 26, 2026 | $2.66 | $2.68 | $2.61 | $2.64 | 483.08K |
| Oct 23, 2026 | $2.83 | $2.83 | $2.60 | $2.66 | 737.35K |
| Oct 22, 2026 | $2.66 | $2.85 | $2.66 | $2.85 | 661.9K |
| Oct 21, 2026 | $2.71 | $2.855 | $2.66 | $2.68 | 942.24K |
| Oct 20, 2026 | $2.85 | $2.98 | $2.70 | $2.72 | 660.93K |
| Oct 19, 2026 | $2.84 | $2.90 | $2.79 | $2.85 | 695.64K |
Latest BBOT news
The latest Smart Investors Daily articles mentioning BBOT.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News

